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PURPOSE. The corneal endothelium is responsible for the correct hydration of the corneal
stroma. Corneal endothelial cells have a low proliferative capacity, so preserving their barrier
function under suboptimal conditions that cause osmotic imbalance, such as those arising
from corneal pathologies, age, cryopreservation, and transplantation, is essential for
maintaining corneal transparency. We have investigated the signaling induced by hyperos-
motic shock that reversibly disrupts corneal endothelial barriers in human endothelial cells
and in murine corneas.
METHODS. Endothelial barrier properties were analyzed in vitro by electric cell substrate
impedance sensing (ECIS) and confocal microscopy of the human endothelial cell line B4G12-
HCEC, and, ex vivo, by confocal microscopy and stimulated emission-depletion (STED) super-
resolution microscopy of murine corneas. Cell signaling in response to hyperosmotic stress,
induced with an excess of sodium chloride, was investigated in B4G12-HCECs. Rho GTPase
activity was detected by pulldown assays with recombinant GST proteins fused to the Rho
binding domains of Rho effectors.
RESULTS. Hyperosmotic stress increased actin polymerization and activated the Rho GTPases
Rac1 and RhoA, but not Cdc42. Rac1- and RhoA-mediated pathway inhibition had a minor
effect on barrier disruption but partially delayed barrier reformation after stress withdrawal.
In contrast, Rac1 and RhoA activation enhanced constitutive endothelial barrier function and
accelerated barrier repair.
CONCLUSIONS. Our results indicate that Rac1 and RhoA activation do not mediate stress-induced
cell contraction but are endothelial responses that act to restore and maintain barrier
homeostasis. Therefore, pharmacological activation of these two GTPases could be a
therapeutic strategy for preserving corneal endothelial barrier function.
Keywords: barrier function, Rac1, osmotic stress, RhoA, ROCK
The corneal endothelium is a monolayer of hexagonal cellslocated between the anterior chamber and the corneal
stroma. The barrier integrity of the endothelium and its active
fluid pump mechanism are involved in maintaining the stromal
deturgescence required for corneal transparency.1–3 Abnormal-
ities in the integrity of the barrier of the corneal endothelium
are observed under pathological conditions such as Fuchs’
dystrophy and uveitis, wherein they are associated with
irreversible corneal swelling, loss of vision, and the need for
transplantation.3,4 Preserving the integrity of the endothelium
is also a major concern in ophthalmic procedures such as
intraocular surgery and corneal transplantation, because
mechanical, inflammatory, and osmotic stress can cause loss
of endothelial cells.5,6 Its role in maintaining corneal deturges-
cence renders the corneal endothelial monolayer particularly
sensitive to osmotic changes, in which the balance between the
transcellular transport of water and ions and the paracellular
pathway mediated by intercellular junctions seems to be critical
for ensuring correct hydration.7 Indeed, corneal endothelial
cells selectively express protein machinery to prevent osmotic
imbalance.8
Although the presence of corneal endothelial progenitor
cells has recently been described in adults,9,10 mature corneas
have a low proliferative capacity.10 In this respect, improving
endothelial barrier function under homeostatic conditions and
in response to stress is crucial for maintaining corneal
functionality, even at reduced endothelial cell density. Endo-
thelial barrier function depends on cell–cell junctions, of which
tight junctions (TJs) are essential in the corneal endothelium.7
In addition, tight junctional complexes associate with the
perijunctional actin cytoskeleton through linker proteins, such
as zonula occludens-1 (ZO-1). Perijunctional actin stabilizes
cell–cell junctions, but also mediates cell contraction and
junctional disruption.11
The Rho family of GTPases comprises more than 20
members, of which RhoA, Rac1, and Cdc42 are the main
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regulators of the cell–cell junctions and the underlying
actomyosin network. The RhoA-mediated pathway can play
opposing functions by increasing the assembly of actomyosin
filaments during cell contraction, disrupting cellular barriers,
and stabilizing cell–cell junctions in various cell types.12,13 This
pathway is mainly controlled by protein phosphorylation
mediated by its effectors, the Rho kinases (ROCKs). ROCKI
and ROCKII enhance actomyosin contractility by inactivating
myosin phosphatase and promoting myosin light chain (MLC)
phosphorylation.14,15 In addition, Rac and Cdc42 activities are
required to maintain barrier integrity16–19 by mediating the
formation of actin filaments that associate with proteins from
junctional complexes, such as ZO-1 and a-catenin at the cell
periphery.20 Tight and adherens junctions form complexes
with GTPase exchange factors that locally activate RhoA, Rac,
and Cdc42. These interactions not only induce a local increase
in F-actin, but also regulate the endocytosis, recycling, and
degradation of junctional protein complexes.21,22 The function
of each of these Rho GTPases in regulating integrity of corneal
endothelial barriers has not yet been addressed in detail, but
the analysis of downstream signaling proteins, such ROCK and
nonmuscle myosin II, suggests that at least RhoA is involved in
corneal endothelial barrier function.23–25
With the ultimate aim of preserving corneal endothelial
barrier function, we have investigated signals underlying the
endothelial response to stress, and then targeted them with
pharmacological inhibitors and activators to investigate their
role. We have found that hyperosmotic stress activates RhoA
and Rac1 but not Cdc42. The inhibition of pathways controlled
by RhoA and Rac1 had a moderate effect on barrier contraction
and delayed barrier recovery after the withdrawal of stress. In
contrast, pharmacological RhoA and Rac1 activation greatly
improved endothelial barrier recovery, which suggests that
RhoA and Rac1 activation are major homeostatic responses of
these cells by which they try to recover their barrier
properties. Thus, in corneal endothelium, RhoA and Rac1
activation increase barrier function and could be therapeutic
targets for preserving corneal functionality.
MATERIALS AND METHODS
Animals
Three-month-old female CD1 mice were used as a source of
corneal tissue. All animal manipulations were carried out in
accordance with Spanish (RD53/2013) and European (86/609/
ECC) regulations, and were approved by the institutional
Animal Care and Use Committee of Centro de Biolog´ıa
Molecular Severo Ochoa and Consejo Superior de Investiga-
ciones Cient´ıficas. All efforts were made to minimize suffering
of the mice. The authors adhered to the ARVO animal
statement.
Chemicals and Antibodies
RhoA inhibitor (C3-transferase), RhoA/Rac1/Cdc42 activator
(Rho activator I), RhoA activator (Rho activator II) were
purchased from Cytoskeleton (Denver, CO, USA). ROCK
inhibitor (Y-27632) and Rac1 inhibitor (Ehop) were obtained
from Sigma-Aldrich (St. Louis, MO, USA). Anti-ZO-1 antibody
was from Zymed Laboratories (San Francisco, CA, USA), anti-
RhoA and anti-ERk1/2 antibodies were from Santa Cruz (Dallas,
TX, USA), and anti-Rac1 and anti Cdc42 antibodies were from
BD Transduction Laboratories (San Jose´, CA, USA). TRITC-
conjugated phalloidin was obtained from Sigma-Aldrich.
Peroxidase conjugated affinipure donkey anti-mouse IgG and
anti-rabbit IgG were purchased from Jackson Immunoresearch
(West Grove, PA, USA). Alexa 488 donkey anti-rabbit IgG was
obtained from ThermoFisher (Waltham, MA, USA).
Human Corneal Specimens
Human corneal tissue was obtained from remnants of donor
grafts after central donor trephination prior to keratoplasty.
Donors had no history of eye disease, ocular surgery, or any
other systemic disease that might have affected the corneas.
Corneal rims were maintained in culture with Tissue C medium
at 318C in a humidified atmosphere containing 5% CO2.
Endothelial Cell Culture
The human corneal endothelial cell line B4G12 (HCEC) was
cultured as described elsewhere.26 Briefly, cells were grown in
human endothelial serum-free medium from Gibco-Thermo
Fisher Scientific (Waltham, MA, USA), supplemented with 20
ng/mL of FGF-2. Cells were cultured on plastic dishes
precoated with 150 lg/mL rat collagen-I, at 378C in a
humidified atmosphere containing 5% CO2. Human umbilical
vein endothelial cells (HUVECs) were obtained and cultured as
described.27 Briefly, HUVECs were obtained by digesting the
vein of umbilical cords with 0.1% collagenase at 378C for
20 minutes (after approval by the donor and the ethics
committee). Endothelial cells were collected and grown on
fibronectin-coated flasks (10 lg/mL; Nunclon, ThermoFisher)
with EBM-2 medium supplemented with 2% FBS and endothe-
lial cell growth factor (EGM-2) following the manufacturer’s
instructions (Lonza, Walkersville, MD, USA). For barrier
function assays, HCECs were cultured at confluence for a
minimum of 48 hours prior to carrying out the experiments. To
attain confluence, 2 3 105 cells per well were seeded in the
ECIS 8WE10 arrays and in the l-Slide eight-well dishes
containing plastic polymer coverslips from Ibidi (Martinsried,
Germany), and 3 3 106 cells were seeded on 60-mm diameter
plastic dishes to perform pulldown assays.
Osmotic Stress in HCECs and Thrombin
Stimulation in HUVECs
Hyperosmotic shock in HCECs was induced as follows. Cells
were starved for 1 hour with Hank’s balanced salt solution
(HBSS) to reduce cell signaling from nutrients and growth
factors and to control the pH when cells were manipulated
outside of the incubator. Human corneal endothelial cells
were either not treated or exposed for 1 to 60 minutes to
HBSS supplemented with NaCl at concentrations from 50 to
600 mM, depending on the assay, or to HBSS supplemented
with 10% to 20% of mannitol for 1 to 10 minutes. Hypo-
osmotic stress was induced by exposing cells to HBSS diluted
with 25% or 50% H2O for 1 to 10 minutes. To promote the
reassembly of TJs after osmotic stress, supplemented or
diluted HBSS was replaced with fresh HBSS and incubated for
a maximum of 180 minutes. As control experiments to
address the efficacy of Y-27632 and C3-transferase, HUVECs
were seeded at confluence on the l-Slide dishes precoated
with fibronectin (10 lg/ml) and pretreated, when indicated,
with 5 lm Y-27632 (for 30 minutes) or 0.5 lg/ml C3-
transferase (for at least 2 hours) before stimulation with 1 U/
ml thrombin for 30 minutes.
Osmotic Stress in Murine Corneas
Dissection and whole-mount staining of mature corneas were
performed as follows. Eyes were dissected out and placed into
Tissue C medium (TC). After iris and lens removal, corneas
were exposed to TC alone or TC supplemented with 225 mM
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NaCl, inducing osmotic stress for 2 hours. This excess of NaCl
induced reversible barrier disruption without significant
cellular damage. Endothelial barrier recovery was measured
after replacing hyperosmotic TC solution with fresh TC.
Corneas were pretreated with Y-27632 (5 lM) in TC for 30
minutes before the hyperosmotic shock in order to analyze the
effect of ROCK inhibition on TJ disassembly. Y-26632 was
maintained throughout the experiment to examine its effect
during the recovery of endothelial barrier. For RhoA inhibition,
corneas were treated with C3-transferase (1 lg/mL) for 4 hours
before exposure to osmotic stress. To analyze the effect of
RhoA signaling inhibition during the recovery of barrier
integrity, inhibitors were added in TC after osmotic stress
withdrawal and maintained for 8 hours in TC. Experiments
with Rho activator I (1 lg/mL) and RhoA activator II (5 lg/mL)
were performed in a similar manner to those described for the
inhibitors. Corneas were pretreated with these activators for 2
hours before osmotic stress to analyze their effect on TJ
disruption. To analyze their involvement in the endothelial
barrier recovery, hyperosmotic TC was replace with TC
containing the activators at the indicated concentrations.
Measurement of TEER (ECIS Assay)
Human corneal endothelial cells (2 3 105 cells per well) were
seeded on eight-well arrays (8WE10) from Ibidi, containing 10
gold electrodes per well. Wells were precoated with rat-
collagen-I. Forty-eight to 72 hours later, transendothelial electric
resistance (TEER) was measured in the arrays with the 1600R
electric cell substrate impedance sensing (ECIS) system from
Applied Biophysics (Troy, NY, USA). Each experimental condi-
tion was measured in duplicate in each experiment. Before
applying the osmotic stress, TEER was measured to verify that
the cell monolayer had reached a steady state. Cells were starved
with HBSS for 1 hour, which had no significant effect on TEER,
and then subjected to stress as described. TEER values were
normalized with respect to those obtained before the osmotic
shock. During NaCl treatment, TEER was monitored for a
maximum of 1 hour and, after stress withdrawal, TEER changes
were recorded for 2 hours to analyze junction reformation. The
percentage of TEER reduction induced by the different
experimental conditions was calculated taking into account
the average normalized resistance (NR) for ECIS electrodes
containing fully contracted cells (observed in NaCl-treated cells)
and the average NR of untreated cells (control confluent
monolayers produced an average NR value of approximately 1
at the beginning of the experiment). The percentage of
reduction in TEER was calculated as [(1  NR experimental
condition) / (1  NR NaCl)3 100].27,28
Pulldown Assays for Measuring Rho GTPase Activity
The levels of activated GTP-bound Rho, Rac, and Cdc42 were
measured by pulldown assays.29 Briefly, confluent HBSS-
starved HCECs were exposed to the indicated osmotic stress
for 0, 2, and 10 minutes. Cells were lysed on ice with 0.5 mL of
lysis buffer containing 50 mM Tris pH 7.5, 10 mM MgCl2, 0.5 M
NaCl, 1% Triton X-100, 10% glycerol, 1 mM EDTA pH 8, 0.5%
sodium deoxycholate, 0.1 % SDS, 1 mM phenylmethylsulfonyl
fluoride, 1 mM sodium orthovanadate, and 10 lg/mL leupetin,
aprotinin, and pepstatin. Two lysates from two culture dishes
of 10-cm diameter were pooled per condition. Cell lysates were
centrifuged for 5 minutes at 16250g at 48C. An aliquot of each
postnuclear supernatant was kept to measure total Rho protein
levels. The supernatants were then incubated with the 10-lg
recombinant GST proteins previously bound to glutathione-
Sepharose beads for 40 minutes at 48C. Rho proteins bound to
recombinant GST proteins were pulled down by centrifugation
for 60 s at 1010g at 48C. Pulldowns were thoroughly washed
with lysis buffer by three additional low-speed centrifugations.
Active RhoA was precipitated by pulldown with GST-rhotekin-
RBD, a chimeric GST protein containing the Rho binding
domain (RBD) of a RhoA effector called rhotekin. Active Rac1
and Cdc42 were isolated by pulldown with GST-PAK-PBD,
which contains the Rac1 and Cdc42 (p21) binding domain
(PBD) of the common effector p21 activated kinase (PAK)-1.
After the pulldown was completed, 10 lL of the initial
postnuclear supernatants (total Rho proteins) and 10 lL of
the 30 lL of the final pulldown fraction (active Rho proteins)
were subjected to SDS-PAGE in 12% acrylamide gels under
reducing conditions and transferred to Immobilon-P mem-
branes (Millipore, Darmstadt, Germany). After blocking with
5% nonfat dry milk, 0.05% (vol/vol) Tween20 in PBS, the
membranes were incubated with antibodies against RhoA,
Rac1, and Cdc42. ERK1/2 was blotted as a loading control.
After extensive washes, the membranes were developed using
an enhanced chemiluminescence Western blotting kit (ECL; GE
Healthcare Life Sciences, Piscataway, NJ, USA). The increase in
GTP-loading of Rho proteins with respect to unstimulated cells
was determined in the Western blots by calculating the ratio
between band intensity in the pulldown lanes (active) and the
corresponding band intensity in the lanes containing post-
nuclear supernatants (total), normalized by the loading
controls. Statistical analysis was calculated from a minimum
of three independent experiments.
Immunofluorescence, Confocal Microscopy, and
Stimulated Emission Depletion Super-Resolution
Microscopy
Corneas, HCECs, and HUVECs were fixed for 1 hour in 4%
paraformaldehyde (PFA) and then stored in PBS at 48C. Cells
were permeabilized using 0.2% Triton X-100 for 5 minutes on
ice. After blocking with 3% BSA in PBS for 1 hour at room
temperature, corneas were incubated overnight at 48C in
blocking solution containing rabbit anti-ZO-1 primary antibody
(1:400). For detection, Alexa Fluor-coupled secondary rabbit
antibody (1:1000) was used. This was followed by staining for F-
actin with TRITC-conjugated phalloidin (1:4000). Tight junc-
tions distribution was measured as the percentage of cell
junction area containing ZO-1, using the F-actin staining with
phalloidin to detect cellular morphology and total cell-cell
junction area. The changes in total F-actin fluorescence intensity
during the osmotic stress assays were quantified with the ImageJ
software (http://imagej.nih.gov/ij/; provided in the public
domain by the National Institutes of Health, Bethesda, MD,
USA) by measuring the raw integrated intensity from confocal
images of HCECs stained with TRITC-conjugated phalloidin,
taken under the same laser power and gain conditions. An
average of 17 cells per image, from eight images taken per
experimental condition, performed as technical duplicates (4
images per coverslip) in each experiment, from at least three
independent experiments, were analyzed. Perijunctional ZO-1 in
murine corneas was quantified from three different images per
experiment, each containing an average of 20 cells. Perijunc-
tional ZO-1 was quantified in 10 representative cells per image
from a minimum of three independent experiments. Stimulated
emission depletion (STED) super-resolution microscopy, was
carried out on a Leica TCS SP5 II STED microscope (Leica,
Wetzlar, Germany), with STED being used to detect fluores-
cence from the ATTO-647N fluorophore. Excitation was carried
out by a 635-nm pulsed diode laser; de-excitation was done by a
MaiTai tunable fs laser at 750 nm. Super-resolution images are
presented in inverted gray scale format to ensure the features
are displayed clearly.
Homeostatic RhoA and Rac1 Activation Upon Stress IOVS j November 2016 j Vol. 57 j No. 14 j 6212
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/Journals/IOVS/935850/ on 12/22/2016
Statistical Analysis
The data were summarized as the mean 6 SEM. Pairs of groups
were compared using Student’s t-test (parametric data). Values
of P less than or equal to 0.05 were considered to be
statistically significant, with critical values indicated as: *P <
0.05; **P < 0.01; and ***P < 0.001. All statistical analyses were
performed using SPSS 15.0 for Windows (Armonk, NY, USA).
RESULTS
Osmotic Stress Alters the Barrier Properties of
Human Endothelial Cells
In order to investigate the signals activated in response to
hyperosmotic stress, we exposed confluent monolayers of the
HCEC line B4G1226 to increasing concentrations of mannitol
and sodium chloride (NaCl). These treatments provoked a
reduction in TEER, measured with an ECIS system, which is
indicative of a decrease in endothelial barrier function (Fig.
1A). Conversely, hypo-osmotic stress had an opposite effect
and increased TEER. These effects were transient and did not
induce significant cellular loss, because TEER values recovered
after withdrawal of the osmotic challenge. Parallel confocal
analysis of these cells revealed that hypertonicity dispersed the
TJ component ZO-1 from cell–cell junctions, whereas hypoto-
nicity did not significantly alter the distribution of this protein
(Figs. 1B, 1C). Hyperosmotic stress also increased F-actin
levels, suggesting that it affected actomyosin-mediated con-
traction (Fig. 1D). Nonmuscle myosin II isoforms are protein
motors that interact with F-actin and increase actomyosin
contractility. Myosin activity is controlled by the MLC, which
becomes active upon phosphorylation in a serine residue at
position 19. In accordance with the increase in F-actin levels,
FIGURE 1. Effect of osmotic stress on corneal endothelial barrier function. (A) Left: measurements of changes in TEER in confluent HCECs exposed
to the indicated HBSS solutions containing the indicated excess of H20, mannitol, and NaCl. These treatments induce reversible changes in barrier
function upon 10-minute exposure to osmotic stress. Right: quantification of TEER reduction after 10-minute exposure to the indicated osmotic
stresses. Maximum TEER reduction (100%) in HCECs was obtained by incubation with 600-mM excess NaCl for 20 minutes. (B) Effect of osmotic
stress on the TJ marker ZO-1. (C) Quantification of the junctional area positive for ZO-1 in cells exposed to 25% excess of H2O (hypo-osmotic), 300-
mM excess NaCl (hyperosmotic), and 20% mannitol (hyperosmotic), normalized with respect to HCECs in iso-osmotic conditions (HBSS). (D)
Quantification of F-actin levels in cells exposed to 25% excess of H2O, 300-mM excess of NaCl, and 20% mannitol, normalized with respect to HCECs
in HBSS. (E) Effect of the indicated osmotic stress on the phosphorylation in Ser19 of myosin light chain (p(Ser19)MLC). Right graph, quantification
of the ratio between p(Ser19)MLC and total MLC levels detected by Western blot in cells exposed to 10 minutes of the indicated stress in three
different experiments. Graphs represent the mean þ SEM *P < 0.05; **P < 0.005. Scale bar: 10 lm.
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MLC phosphorylation, detected by Western blot with an
antibody against the phosphorylated (p) S19 of MLC, increased
in cells exposed to hyperosmotic stress, but not to hypo-
osmotic stress (Fig. 1E).
We performed similar experiments with corneas ex vivo to
address the effect of hyperosmotic stress in response to salt
excess, which occurs in vivo, for instance, in the stroma of
corneas lacking ion transporters.8 First, murine corneas were
dissected out and exposed to a range of hyperosmotic stress
conditions (not shown). Consistent with the reduction in
TEER observed in the corneal cell line, the formation of
intercellular gaps became evident in murine endothelium
exposed to an excess of 225-mM NaCl between 1 and 2 hours,
as shown by the ZO-1 distribution (Fig. 2A). ZO-1 was linearly
distributed between the two perijunctional actomyosin rings
(PAMRs), characteristic of these hexagonal cells, under iso-
osmotic conditions (Fig. 2A, enlarged areas). In response to the
osmotic shock, the PAMR increased, whereas ZO-1 disap-
peared in some junctional domains and acquired a more
punctate and intense distribution in some others, which
overlapped with the F-actin staining (Fig. 2A, bottom images).
This overlapping increase in the distribution of the remaining
junctional ZO-1 and F-actin was also observed in human
endothelium from corneoscleral rims subjected to increasing
concentrations of NaCl (Fig. 2B). We then investigated in more
detail the changes in F-actin and ZO-1 distribution upon
hyperosmotic stress by analyzing the murine corneas by super-
resolution confocal microscopy. STED microscopy of the
PAMR revealed a perijunctional actin ring formed by bundles
of actin filaments (Fig. 2C, arrowheads). Adjacent PAMR
appeared connected by F-actin filaments emerging perpendic-
ular to the main actin ring (Fig. 2C, enlarged areas). However,
ZO-1 did not colocalize with these F-actin structures. Upon
hyperosmotic stress, ZO-1 was dispersed and the PAMR and
the perpendicular F-actin connections increased in size and
intensity. Interestingly, the ZO-1 clusters that remained at cell
borders aligned with these F-actin bundles, suggesting that
they mediate the disruption of TJs in response to stress (Fig.
2C, enlarged areas).
RhoA and Rac1, but Not Cdc42, Are Activated in
Response to Hyperosmotic Stress
To further address the cell responses induced by hyperosmotic
stress, we analyzed the activity of the Rho GTPAses RhoA,
Rac1, and Cdc42, which are the master regulators of the actin
cytoskeleton and cell barrier function, and are expressed in the
mature corneal endothelium.30 In their active state, most
GTPases are loaded with GTP. We examined the GTP-bound
state of RhoA, Rac1, and Cdc42, by pulldown assay with
recombinant proteins containing Rho-binding domains from
Rho effectors that specifically bind these GTP-loaded (active)
Rho proteins (Figs. 3A, 3B). We compared the levels of RhoA
and Rac1 expression in the cell lysates (Total) with those in the
pulldown fractions, which correspond to the GTP-loaded
forms of RhoA and Rac1 bound to the recombinant proteins
(Active), by Western blot with anti-RhoA and Rac1-specific
antibodies. RhoA- and Rac1-GTP levels increased significantly
in response to hyperosmotic shock (Fig. 3). In contrast, Cdc42
activation was minor and not statistically significant. We
detected an increase in RhoA and Rac1 activity with an excess
of NaCl as low as 50 mM (Fig. 3A), although this was more
moderate than with an excess of 150-mM NaCl (Fig. 3B). These
results demonstrate that hyperosmotic stress activates the
signaling pathways controlled by RhoA and Rac1, but not
Cdc42, in HCECs.
RhoA and Rac1 Inhibition Do Not Prevent
Endothelial Barrier Disruption and Delays Barrier
Recovery After Stress Withdrawal
To gain insights into the role of RhoA in disrupting the
corneal endothelial barrier after osmotic stress, we pretreated
cells with C3 transferase, a specific inhibitor of Rho,
conjugated to a permeable peptide.31,32 C3 transferase
FIGURE 2. Effect of hyperosmotic stress in the endothelium of murine
and human corneas. (A) Murine adult corneas were dissected out and
incubated in HBSS or in HBSS containing an excess of 225 mM NaCl for
1 hour, fixed, and stained for ZO-1 and for F-actin. (B) Human
corneoscleral rims were donated after transplantation and incubated in
HBSS or in HBSS containing 300 mM NaCl for 1 hour, fixed, and stained
for ZO-1 and for F-actin. Scale bars: 20 lm. (C) Imaging TJs and the
PAMR by super-resolution confocal microscopy. Dissected murine
corneas were incubated in HBSS or in HBSS containing 225 mM NaCl
for 1 hour, fixed, and stained for ZO-1 and for F-actin. STED microscopy
reveals bundles of actin filaments parallel to the cell border (arrows)
and perpendicular actin connections between cells (see enlargements
of the STED images). ZO-1 is localized in areas between cells with low
F-actin staining (see enlargement of the squared area in the ZO-1/F-
actin image). With an excess of NaCl, the PAMR and the perpendicular
F-actin connections increase in size and intensity and ZO-1 clusters
align with the F-actin connections between adjacent PAMRs. Right
images in each panel correspond to enlargements of the correspond-
ing squared areas. Scale bars: 5 lm.
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selectively ribosylates RhoA in its effector binding domain,
inducing a shift in its molecular weight and inactivating it, as
shown by pulldown assay (Supplementary Fig. S1A).29 C3
transferase did not attenuate TEER decrease during NaCl
exposure (Fig. 4A, Supplementary Fig. S1B). However, after
stress withdrawal, C3 transferase caused a moderate but
statistically significant delay in endothelial barrier recovery
(Fig. 4A, Supplementary Fig. S1B). Among the many RhoA
effectors, the Rho kinase (ROCK) controls cellular barrier
function and mediates actomyosin contractility in different
cellular settings.15 The ROCK inhibitor Y-27632, moderately
attenuated TEER decrease during hyperosmotic shock and
slightly delayed subsequent barrier recovery after the return
to iso-osmolarity (Fig. 4B, Supplementary Fig. S1C). To
address the role of Rac1, we pretreated cells with Ehop-
01633 and analyzed endothelial barrier function. Ehop-016
inhibited Rac1 activity in HCEC exposed to hyperosmotic
shock (Supplementary Fig. S1A). However, EHop-016 modi-
fied neither TEER decrease during hyperosmotic treatment,
nor barrier function recovery (Fig. 4C, Supplementary Fig.
S1D). Pretreatment of HCEC with C3 and Y-27632 reduced
thrombin-mediated contraction to a lesser extent than what
was previously found in other cell monolayers27,34 (Fig. 4D).
Therefore, although we observed a clear activation of RhoA
and Rac1 in response to a hypertonic shock, their inhibition
had a minor effect on HCEC barrier disruption. Moreover,
inhibiting RhoA-mediated signaling slightly delayed barrier
recovery upon stress withdrawal.
To confirm the moderate effect of Rho and ROCK
inhibition on barrier reformation, we performed similar
experiments with ex vivo murine corneas. These were
dissected out and exposed to hyperosmotic stress induced
with an excess of NaCl (Supplementary Fig. S2). Although
murine endothelium pretreated with RhoA signaling inhibitor
(C3 transferase) had lower endothelial F-actin levels than the
untreated endothelium before the stress, C3-transferase did
not inhibit the increase in the perijunctional F-actin staining
occurring in response to the stress (Fig. 5A). Ex vivo barrier
reformation assays were performed by exposing the corneas to
hypertonic stress and then, when indicated, incubating them
with the inhibitors after stress withdrawal (Fig. 5B). This
confirmed that osmotic stress did not affect cell viability,
because ZO-1 perijunctional staining was fully recovered 8
hours after its removal. We quantified the percentage of ZO-1
FIGURE 3. Hyperosmotic stress activates RhoA and Rac1 but not Cdc42. Pulldown assays of RhoA, Rac1, and Cdc42 in confluent HCEC subjected to
hyperosmotic stress of (A) 50-mM excess NaCl for the indicated times, and of (B) 150-mM excess NaCl for 10 minutes. Graphs show the
quantification of active Rho normalized to total Rho levels from at least three experiments and represent the mean þ SEM. *P < 0.05.
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at cell borders in cells exposed or not exposed to stress, as
well as in the barrier reformation assays, in the presence or
absence of C3-transferase (Figs. 5C, 5D). Quantification
revealed that the loss of TJs was not prevented by C3-
transferase (Figs. 5A, 5D), suggesting that RhoA is not
determinant for barrier disruption. In addition, C3-transferase
clearly prevented cell–cell junction recovery (Figs. 5B–D). To
determine the role of the RhoA effector ROCK in regulating
the endothelial barrier function in murine corneas, we next
analyzed the effect of Y-27632 on barrier disruption and
recovery following the same quantification procedure (Fig.
5C). Similar to C3-transferase, Y-27632 had no effect on ZO-1
dispersion (Figs. 6A, 6C) but clearly prevented TJ reformation
after stress withdrawal (Figs. 6B, 6C). Again, a reduction of F-
actin levels in the presence of Y-27632 was observed before
but not after, osmotic stress.
Finally, as a positive control of the effect of C3-transferase
and Y-27632, HUVECs were stimulated with thrombin in the
presence or absence of these inhibitors. Thrombin is a
paradigmatic inflammatory mediator that induces F-actin in
HUVECs by activating the RhoA-ROCK pathway.35,36 C3-
transferase and Y-27632 clearly reduced the F-actin staining in
unstimulated and thrombin-stimulated HUVECs (Supplementa-
ry Fig. S3) as previously described.34,35 Thus, similar to our in
vitro results, our findings indicate that RhoA signaling is not
required for acute contraction but for the restoration of
endothelial barrier properties in murine corneas. RhoA and
ROCK inhibitors prevented tight junction reformation, but had
no effect on F-actin level increase in response to the osmotic
stress in the corneal endothelium.
Rho and Rac1 Activation Attenuate Endothelial
Barrier Disruption and Accelerate Barrier
Recovery After Stress
Inhibition of signaling pathways regulated by RhoA affected
TJ reformation and increased the dysfunction. We then
hypothesized that RhoA and Rac1 activation in response to
stress (Fig. 3) are cellular responses that aim to recover the
homeostatic state of the endothelial monolayer. Therefore,
their activation may favor, rather than undermine, barrier
integrity. To address this hypothesis, Rho and Rac1 were
activated with two chimeric proteins containing the catalytic
domain of a cytotoxic necrotizing factor toxin, conjugated to
a penetrating peptide. These catalytic domains block the
GTPase activity of various Rho proteins, resulting in
constitutively active Rho.37 Rho activator-I (Act-I) activates
RhoA, Rac1, and Cdc42, and Rho activator-II (Act-II)
specifically activates RhoA subfamily proteins. Pulldown
assays revealed that Act-I activated Rac1 but had little effect
on Cdc42 in HCECs (Supplementary Fig. S4). Act-I slightly
reduced RhoA activity, probably because this molecule
preferentially activates Rac1, which often negatively regulates
RhoA function. In contrast, Act-II specifically activated RhoA,
but did not induce Rac1 and Cdc42 activity (Supplementary
Fig. S4). Human corneal endothelial cells were treated with
Act-I and Act-II before osmotic stress. Both activators
increased HCEC TEER before the hyperosmotic stress (Figs.
7A, 7B; Supplementary Figs. S5A, S5B) and reduced stress-
induced barrier disruption (Fig. 7A; Supplementary Fig. S5A)
and recovery (Fig. 7B; Supplementary Fig. S5B). Although the
pulldown assays indicated that RhoA was not significantly
FIGURE 4. RhoA-ROCK and Rac1 inhibition do not prevent endothelial barrier dysfunction in response to hyperosmotic stress. Human corneal
endothelial cells were grown to confluency in ECIS arrays containing gold electrodes and TEER was analyzed by ECIS. TEER was normalized relative
to resistance values at the beginning of the assay. Absolute resistance values are shown in Supplementary Figure S1. (A) Effect of C3-transferase (0.5
lg/ml) on barrier contraction induced with 50-mM excess NaCl and the subsequent recovery upon return to iso-osmolarity. (B) Effect of Y-27632 (5
lM) on barrier contraction and the subsequent recovery upon return to iso-osmolarity. (C) Effect of Ehop-016 (5 lM) on barrier contraction and the
subsequent recovery upon return to iso-osmolarity. (D) Effect of C3-transferase and Y-27632 on thrombin-mediated barrier disruption. Graphs
represent the mean þ SEM of at least three different experiments. *P < 0.05.
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activated by Act-I, we also performed experiments with Act-I
in the presence of the ROCK inhibitor Y-27632, which
confirmed that the RhoA pathway does not play a major role
in the increase of Act-I-induced barrier function. Importantly,
Act-I and Act-II significantly increased TEER in the absence of
any stress, indicating a general and positive effect of RhoA
and Rac1 activation on endothelial barrier function. The
protective effect on barrier function was also observed in
FIGURE 5. RhoA inhibition moderately reduces endothelial barrier recovery in murine corneas. Murine corneas were dissected out and subjected to
the indicated treatments. (A) Effect of C3 transferase during hyperosmotic stress. Murine corneas were pretreated, when indicated, with C3-
transferase (1 lg/mL) and then subjected to hyperosmotic stress. Enlarged details of the squared areas are shown to the right of the images. (B)
Effect of C3 transferase during endothelial barrier recovery. Murine corneas were exposed to hyperosmotic stress for 2 hour when indicated (NaCl).
After stress withdrawal, corneas were incubated with C3-transferase when indicated. Enlarged details of the squared areas are shown to the right of
the images. (C, D) Quantification of the junctional area occupied by ZO-1 from images like those in (A) and (B). (C) The PAMR was clearly identified
with phalloidin-TRITC at cell–cell contacts under all experimental conditions, so the peripheral area of each cell could be determined by drawing a
region of interest in ImageJ. The percentage of this area that is positive for ZO-1 staining was then calculated in each treatment. (D) Graph
represents the meanþ SEM of at least three different experiments like those shown in (A) and (B). *P < 0.05; **P < 0.01. Scale bars: 20 lm. Scale
bars in enlarged areas: 4 lm.
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murine corneas, in which Act-I and Act-II reduced ZO-1
dispersion in response to hyperosmotic stress (Fig. 8A) and
accelerated ZO-1 relocalization at cell–cell junctions during
barrier restoration (Fig. 8B), when quantified as in Figure 5C.
Interestingly, the effect of Act-I on barrier restoration required
the presence of the ROCK inhibitor, suggesting that this
activator acts differently on the murine ROCK pathway.
Overall, our results indicate that RhoA and Rac1 are good
targets for preserving and repairing corneal endothelial
barriers under stress.
DISCUSSION
Rho GTPases play pleiotropic roles regulating the actin
cytoskeleton and cell barrier function. In particular, RhoA-
and Rac1-mediated pathways can have opposing effects of
disrupting and preserving cell barrier function, respectively,
and by orchestrating the balance between actomyosin contrac-
tion and barrier reformation in various cell types.19,38–40 At the
same time as being active in mediating actomyosin-mediated
contraction, the Rho-ROCK pathway is also necessary for the
FIGURE 6. ROCK inhibition moderately reduces endothelial barrier recovery in murine corneas. Murine corneas were dissected out and subjected
to the indicated treatments. (A) Effect of Y-27632 during hyperosmotic stress. Murine corneas were pretreated, when indicated, with Y-27632 (5 lM)
and then subjected to hyperosmotic stress. (B) Effect of Y-27632 during endothelial barrier recovery. Murine corneas were exposed to hyperosmotic
stress for 2 hours when indicated (NaCl). After stress withdrawal, the corneas were incubated with Y-27632 when specified. (A, B) Enlarged details
of the squared areas are shown on the right of the images. (C) Quantification of the junctional area occupied by ZO-1 in the stress and recovery
assays was carried out as in Figures 5C and 5D. Graph represents the meanþ SEM of at least three different experiments *P < 0.05; **P < 0.01. Scale
bars: 20 lm. Scale bars in enlarged areas: 4 lm.
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homeostatic maintenance of cellular barriers.13 In vitro
experiments in monolayers of bovine corneal endothelial cells,
in which calcium is removed from the medium to disrupt cell–
cell junctions and adhesions, also suggest a dual role for ROCK
and actomyosin in corneal endothelial barrier disruption and
reformation. On the other hand, the protease thrombin and
histamine induce massive RhoA-dependent actomyosin con-
traction and loss of barrier function in corneal endothelial cells,
suggesting that Rho-ROCK mediates acute contraction in
corneal endothelium in a comparable way to what occurs in
other cell monolayers, such as those of vascular endothelial
cells.25,34,41 Here, we have analyzed the responses of corneal
endothelial cells to hyperosmotic stress in vitro and in murine
corneas and found that barrier disruption is not prevented by
inhibition of the RhoA and Rac1 pathways and that, conversely,
Rho-ROCK-MLC and Rac1 activities are required to maintain the
endothelial barriers. Our results indicate that this does not
occur exclusively in the context of hyperosmotic stress,
because MLC inhibition (not shown) and RhoA and Rac1
activation constitutively reduce and enhance, respectively,
barrier function. Our pulldown assays suggested that the
activation of signaling pathways in response to stress could
mediate barrier disruption or, conversely, could constitute a cell
response to recover homeostatic barrier function. Our results
obtained using inhibitors and activators of these pathways
suggest that RhoA and Rac1 activation in response to stress
induce signaling pathways to homeostatically maintain corneal
endothelial barrier function. Hence, we propose that RhoA-
ROCK and Rac1 activation could be strategies for preserving
endothelial barrier integrity in response to various types of
stress, such as inflammatory, mechanical, and osmotic stress.
It is of note that in order to promote cell barrier remodeling
through cell migration during, for example, corneal wound
healing, it is necessary to reduce the stability of cell–cell
junctions.42 In general, the dissolution of cell–cell junctions is
associated with increased cell adhesion, migration, prolifera-
tion, and cancer.43,44 Y-27632 is currently being used to
promote endothelial cell adhesion and migration for wound
closure and to promote cell engraftment during endothelial
keratoplasty. Given that ROCK inhibition can have a negative
effect on cell migration,45 the positive effect of ROCK inhibitors
in corneal endothelial cells during wound closure46,47 could be
at least partially related to the function of RhoA-ROCK in cell–
cell junction formation. Impairment of cell–cell contacts may
have a positive effect on the capacity of individual endothelial
cells to adhere to the substratum through focal adhesions, as
previously shown in vascular endothelial cells.44
Corneal endothelial cells are indeed very sensitive to cell–
cell contact inhibition that cause mitotic block. Cell–cell
junctions have been perturbed with trypsin EDTA for short
periods to unlock this mitotic block and try to promote corneal
endothelial cell proliferation in the presence of growth factors.
However, this treatment causes epithelial-mesenchymal transi-
tion and endothelial cells acquire a fibroblastic phenotype as a
consequence.48 An alternative and elegant strategy to expand
corneal endothelial cell cultures consisted of knocking down
p120 catenin, a protein from cell–cell junctions, which
induced the activation of the RhoA-ROCK-BMP pathway,
thereby reprogramming HCEC to act as neural crest-like
progenitors. This treatment allowed expansion of HCEC
progenitors until p120-catenin levels were recovered, the
RhoA-ROCK signaling ceased and HCECs reverted to their
original endothelial phenotype.48,49 Here, we show that
hyperosmotic stress recapitulates some of the main require-
ments for HCEC expansion: reversible cell–cell junction
disruption and RhoA-ROCK activation. In addition, active
RhoA and Rac1 participate in noncanonical Wnt signaling,
which is involved in actin remodeling, development, and
epithelial-mesenchymal transition.49,50 Thus, it seems plausible
to hypothesize that hyperosmotic stress may have an effect on
corneal endothelial cell proliferation and differentiation.
The paracellular permeability regulated by cell–cell junc-
tions is essential in the ‘‘pump-leak’’ model proposed to
explain the control of stromal hydration by the corneal
endothelium.51 The hydrophilic nature of stromal glycosami-
noglycans as well as the IOP from the aqueous humor induce a
paracellular passage of liquid toward the stroma that is counter
balanced by the protein machinery of transporters at the
plasma membrane of endothelial cells, which returns ions and
water to the aqueous humor.51,52 When leakiness is excessive,
the pumping mechanisms are not sufficient to prevent corneal
swelling and corneal transparency is reduced. Mutations in
some of these endothelial transporters, such as SLC4A11,
cause corneal osmotic imbalance, congenital hereditary
endothelial dystrophy and Fuchs endothelial corneal dystro-
phy.8,53,54 It is of note that the corneas from the slc4a11
knockout mice increase NaCl concentration in the stroma,
leading to the formation of salt crystals.8 This may be an
FIGURE 7. RhoA and Rac1 activation preserve endothelial barrier function. Human corneal endothelial cells were grown to confluence in ECIS
arrays containing gold electrodes and TEER was analyzed by ECIS. (A) Effect of pretreatment with 1 lg/ml Act-I (RhoA and Rac1), Act-Iþ 5 lM Y-
27632 (Rac1), and 5 lg/mL Act-II (RhoA) on barrier integrity. Contraction upon osmotic stress was induced with an excess of 50 mM NaCl. (B) Effect
of treatment with Act I (RhoA and Rac1 activation), Act-IþY-27632 (Rac1 activation), and Act-II (RhoA activation) during the return to iso-osmolarity
(recovery). To better analyze recovery upon stress withdrawal, cells were exposed to osmotic stress with an excess of 150-mM NaCl, which induced
greater barrier disruption. TEER was normalized with respect to resistance values before the beginning of the assay. Absolute TEER values are shown
in Supplementary Figure S5. Graphs represent the mean þ SEM of at least three different experiments. *P < 0.05; **P < 0.01; ***P < 0.001.
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extreme example of osmotic imbalance, but illustrates the fact
that dysfunction of the pump-leak equilibrium in corneal
pathologies may lead to osmotic stress, which, according to
our results, could induce negative feedback by causing
additional disruption of the endothelial barrier. Small hyper-
tonic perturbations caused by excess NaCl are compensated
by transendothelial fluid transport.55,56 We show that crossing
a certain threshold of hyperosmolarity has a clear effect on
tight junctions and paracellular barrier function. Barrier
dysfunction upon hyperosmotic shock may occur not only in
corneal dystrophies, but also in the manipulation of corneas
during keratoplasty procedures, in which the endothelial cells
and the anterior chamber are subjected to acute osmotic and
mechanical shock. In conclusion, our results demonstrate the
activation of RhoA and Rac1 in response to a stress stimulus
that disrupts the endothelial cell–cell junctions. This activation
has a positive effect on corneal endothelial barrier function
and places these two Rho GTPases at the center of
pharmacological strategies for preserving the integrity of the
corneal endothelium.
FIGURE 8. RhoA and Rac1 activation preserve barrier function in murine corneas. Murine corneas were dissected out and subjected to the indicated
treatments. (A) Left images. Representative images of ZO-1 and F-actin staining in corneal endothelium subjected to the indicated treatments in a
hyperosmotic stress assay (225-mM excess NaCl). Right graph. Quantification of the junctional area occupied by ZO-1 in corneal endothelia
subjected to iso-osmotic (Control) or hyperosmotic (NaCl) treatments in the presence or absence of Act I (RhoA and Rac1 activation), Act I þ Y-
27632 (Rac1 activation), and Act II (RhoA activation). (B) Left images. Representative images of ZO-1 and F-actin staining in corneal endothelium
first subjected to iso-osmotic (Control) or hyperosmotic treatments, and then incubated with iso-osmotic Tissue C to promote barrier recovery
(NaCl). Right graph. Quantification of the junctional area occupied by ZO-1 in corneal endothelia after the barrier recovery assay in the presence or
absence of Act I (RhoA and Rac1 activation), Act IþY-27632 (Rac1 activation), and Act II (RhoA activation). Scale bar:15 lm. Graphs represents the
mean þ S.E.M. of at least three different experiments. * P < 0.05; ** P < 0.01.
Homeostatic RhoA and Rac1 Activation Upon Stress IOVS j November 2016 j Vol. 57 j No. 14 j 6220
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/Journals/IOVS/935850/ on 12/22/2016
Acknowledgments
The authors thank the expert technical advice of the personnel of
the Optical and Confocal Microscopy Facility, the Genomic Facility,
and the Animal Facility of the CBMSO, Madrid. Jose´ Mar´ıa Nu´nez,
the patient who inspired this work, is also acknowledged.
Work supported by ENDOCORNEA, convenio colaboracio´n CSIC -
Instituto de Investigacio´n Sanitaria Fundacio´n Jime´nez Dı´az
(Madrid, Spain), and SAF2014-57950-R from MINECO (Spain).
The authors alone are responsible for the content and writing of
the paper.
Disclosure: M.C. Ortega, None; D. Santander-Garcı´a, None; B.
Marcos-Ramiro, None; S. Barroso, None; S. Cox, None; I.
Jime´nez-Alfaro, None; J. Milla´n, None
References
1. Armitage WJ, Moss SJ, Easty DL. Effects of osmotic stress on
rabbit corneal endothelium. Cryobiology. 1988;25:425–439.
2. Armitage WJ, Dick AD, Bourne WM. Predicting endothelial cell
loss and long-term corneal graft survival. Invest Ophthalmol
Vis Sci. 2003;44:3326–3331.
3. Srinivas SP. Cell signaling in regulation of the barrier integrity
of the corneal endothelium. Exp Eye Res. 2012;95:8–15.
4. Edelhauser HF. The balance between corneal transparency and
edema: the Proctor Lecture. Invest Ophthalmol Vis Sci. 2006;
47:1754–1767.
5. George AJ, Larkin DF. Corneal transplantation: the forgotten
graft. Am J Transplant. 2004;4:678–685.
6. Niederkorn JY. Immune mechanisms of corneal allograft
rejection. Curr Eye Res. 2007;32:1005–1016.
7. Fischbarg J, Diecke FP, Iserovich P, Rubashkin A. The role of
the tight junction in paracellular fluid transport across corneal
endothelium. Electro-osmosis as a driving force. J Membr Biol.
2006;210:117–130.
8. Groger N, Frohlich H, Maier H, et al. SLC4A11 prevents
osmotic imbalance leading to corneal endothelial dystrophy,
deafness, and polyuria. J Biol Chem. 2010;285:14467–14474.
9. Espana EM, Sun M, Birk DE. Existence of corneal endothelial
slow-cycling cells. Invest Ophthalmol Vis Sci. 2015;56:3827–
3837.
10. Joyce NC. Proliferative capacity of corneal endothelial cells.
Exp Eye Res. 2012;95:16–23.
11. Steed E, Balda MS, Matter K. Dynamics and functions of tight
junctions. Trends Cell Biol. 2010;20:142–149.
12. Komarova YA, Mehta D, Malik AB. Dual regulation of
endothelial junctional permeability. Sci STKE. 2007;2007:re8.
13. van Nieuw Amerongen GP, Beckers CM, Achekar ID, Zeeman
S, Musters RJ, van Hinsbergh VW. Involvement of Rho kinase
in endothelial barrier maintenance. Arterioscler Thromb Vasc
Biol. 2007;27:2332–2339.
14. Kimura K, Ito M, Amano M, et al. Regulation of myosin
phosphatase by Rho and Rho-associated kinase (Rho-kinase).
Science. 1996;273:245–248.
15. Riento K, Ridley AJ. Rocks: multifunctional kinases in cell
behaviour. Nat Rev Mol Cell Biol. 2003;4:446–456.
16. Cain RJ, Vanhaesebroeck B, Ridley AJ. The PI3K p110alpha
isoform regulates endothelial adherens junctions via Pyk2 and
Rac1. J Cell Biol. 2010;188:863–876.
17. Samarin S, Nusrat A. Regulation of epithelial apical junctional
complex by Rho family GTPases. Front Biosci (Landmark
Ed). 2009;14:1129–1142.
18. Kouklis P, Konstantoulaki M, Vogel S, Broman M, Malik AB.
Cdc42 regulates the restoration of endothelial barrier func-
tion. Circ Res. 2004;94:159–166.
19. Marcos-Ramiro B, Garcia-Weber D, Millan J. TNF-induced
endothelial barrier disruption: beyond actin and Rho. Thromb
Haemost. 2014;112.
20. Ridley AJ, Schwartz MA, Burridge K, et al. Cell migration:
integrating signals from front to back. Science. 2003;302:
1704–1709.
21. Quiros M, Nusrat A. RhoGTPases actomyosin signaling and
regulation of the epithelial apical junctional complex. Semin
Cell Dev Biol. 2014;36:194–203.
22. Citi S, Guerrera D, Spadaro D, Shah J. Epithelial junctions and
Rho family GTPases: the zonular signalosome. Small GTPases.
2014;5:1–15.
23. Satpathy M, Gallagher P, Lizotte-Waniewski M, Srinivas SP.
Thrombin-induced phosphorylation of the regulatory light
chain of myosin II in cultured bovine corneal endothelial cells.
Exp Eye Res. 2004;79:477–486.
24. Satpathy M, Gallagher P, Jin Y, Srinivas SP. Extracellular ATP
opposes thrombin-induced myosin light chain phosphoryla-
tion and loss of barrier integrity in corneal endothelial cells.
Exp Eye Res. 2005;81:183–192.
25. Srinivas SP, Satpathy M, Guo Y, Anandan V. Histamine-induced
phosphorylation of the regulatory light chain of myosin II
disrupts the barrier integrity of corneal endothelial cells.
Invest Ophthalmol Vis Sci. 2006;47:4011–4018.
26. Valtink M, Gruschwitz R, Funk RH, Engelmann K. Two clonal
cell lines of immortalized human corneal endothelial cells
show either differentiated or precursor cell characteristics.
Cells Tissues Organs. 2008;187:286–294.
27. Marcos-Ramiro B, Oliva Nacarino P, Serrano-Pertierra E, et al.
Microparticles in multiple sclerosis and clinically isolated
syndrome: effect on endothelial barrier function. BMC Neuro-
sci. 2014;15:110.
28. Marcos-Ramiro B, Garcia-Weber D, Barroso S, et al. RhoB
controls endothelial barrier recovery by inhibiting Rac1
trafficking to the cell border. J Cell Biol. 2016;213:385–402.
29. Ren XD, Schwartz MA. Determination of GTP loading on Rho.
Methods Enzymol. 2000;325:264–272.
30. Mitchell DC, Bryan BA, Liu JP, et al. Developmental expression
of three small GTPases in the mouse eye. Mol Vis. 2007;13:
1144–1153.
31. Aktories K, Barbieri JT. Bacterial cytotoxins: targeting eukary-
otic switches. Nat Rev Microbiol. 2005;3:397–410.
32. Aktories K, Hall A. Botulinum ADP-ribosyltransferase C3: a
new tool to study low molecular weight GTP-binding proteins.
Trends Pharmacol Sci. 1989;10:415–418.
33. Montalvo-Ortiz BL, Castillo-Pichardo L, Hernandez E, et al.
Characterization of EHop-016 novel small molecule inhibitor
of Rac GTPase. J Biol Chem. 2012;287:13228–13238.
34. Fernandez-Martin L, Marcos-Ramiro B, Bigarella CL, et al.
Crosstalk between reticular adherens junctions and platelet
endothelial cell adhesion molecule-1 regulates endothelial
barrier function. Arterioscler Thromb Vasc Biol. 2012;32:e90–
e102.
35. McKenzie JA, Ridley AJ. Roles of Rho/ROCK and MLCK in TNF-
alpha-induced changes in endothelial morphology and perme-
ability. J Cell Physiol. 2007;213:221–228.
36. Wojciak-Stothard B, Entwistle A, Garg R, Ridley AJ. Regulation
of TNF-alpha-induced reorganization of the actin cytoskeleton
and cell-cell junctions by Rho, Rac and Cdc42 in human
endothelial cells. J Cell Physiol. 1998;176:150–165.
37. Schmidt G, Sehr P, Wilm M, Selzer J, Mann M, Aktories K. Gln
63 of Rho is deamidated by Escherichia coli cytotoxic
necrotizing factor-1. Nature. 1997;387:725–729.
38. Vandenbroucke E, Mehta D, Minshall R, Malik AB. Regulation
of endothelial junctional permeability. Ann N Y Acad Sci.
2008;1123:134–145.
Homeostatic RhoA and Rac1 Activation Upon Stress IOVS j November 2016 j Vol. 57 j No. 14 j 6221
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/Journals/IOVS/935850/ on 12/22/2016
39. Beckers CM, van Hinsbergh VW, van Nieuw Amerongen GP.
Driving Rho GTPase activity in endothelial cells regulates
barrier integrity. Thromb Haemost. 2010;103:40–55.
40. Schlegel N, Meir M, Spindler V, Germer CT, Waschke J.
Differential role of Rho GTPases in intestinal epithelial barrier
regulation in vitro. J Cell Physiol. 2011;226:1196–1203.
41. Shivanna M, Jalimarada SS, Srinivas SP. Lovastatin inhibits the
thrombin-induced loss of barrier integrity in bovine corneal
endothelium. J Ocul Pharmacol Ther. 2010;26:1–10.
42. Savagner P. Epithelial-mesenchymal transitions: from cell
plasticity to concept elasticity. Curr Top Dev Biol. 2015;112:
273–300.
43. Lu Z, Ghosh S, Wang Z, Hunter T. Downregulation of caveolin-
1 function by EGF leads to the loss of E-cadherin, increased
transcriptional activity of beta-catenin and enhanced tumor
cell invasion. Cancer Cell. 2003;4:499–515.
44. Millan J, Cain RJ, Reglero-Real N, et al. Adherens junctions
connect stress fibres between adjacent endothelial cells. BMC
Biol. 2010;8:11.
45. Sanz-Moreno V, Gaggioli C, Yeo M, et al. ROCK and JAK1
signaling cooperate to control actomyosin contractility in
tumor cells and stroma. Cancer Cell. 2011;20:229–245.
46. Pipparelli A, Arsenijevic Y, Thuret G, Gain P, Nicolas M, Majo F.
ROCK inhibitor enhances adhesion and wound healing of
human corneal endothelial cells. PLoS One 2013;8:e62095.
47. Okumura N, Koizumi N, Ueno M, et al. Enhancement of
corneal endothelium wound healing by Rho-associated kinase
(ROCK) inhibitor eye drops. Br J Ophthalmol. 2011;95:1006–
1009.
48. Zhu YT, Chen HC, Chen SY, Tseng SC. Nuclear p120 catenin
unlocks mitotic block of contact-inhibited human corneal
endothelial monolayers without disrupting adherent junc-
tions. J Cell Sci. 2012;125:3636–3648.
49. Zhu YT, Li F, Han B, et al. Activation of RhoA-ROCK-BMP
signaling reprograms adult human corneal endothelial cells. J
Cell Biol. 2014;206:799–811.
50. Wynshaw-Boris A. Dishevelled: in vivo roles of a multifunc-
tional gene family during development. Curr Top Dev Biol.
2012;101:213–235.
51. Bonanno JA. Molecular mechanisms underlying the corneal
endothelial pump. Exp Eye Res. 2012;95:2–7.
52. Srinivas SP. Dynamic regulation of barrier integrity of the
corneal endothelium. Optom Vis Sci. 2010;87:E239–E254.
53. Vithana EN, Morgan PE, Ramprasad V, et al. SLC4A11
mutations in Fuchs endothelial corneal dystrophy. Hum Mol
Genet. 2008;17:656–666.
54. Vithana EN, Morgan P, Sundaresan P, et al. Mutations in
sodium-borate cotransporter SLC4A11 cause recessive con-
genital hereditary endothelial dystrophy (CHED2). Nat Genet.
2006;38:755–757.
55. Sanchez JM, Li Y, Rubashkin A, et al. Evidence for a central role
for electro-osmosis in fluid transport by corneal endothelium.
J Membr Biol. 2002;187:37–50.
56. Ruberti JW, Klyce SD. NaCl osmotic perturbation can
modulate hydration control in rabbit cornea. Exp Eye Res.
2003;76:349–359.
Homeostatic RhoA and Rac1 Activation Upon Stress IOVS j November 2016 j Vol. 57 j No. 14 j 6222
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/Journals/IOVS/935850/ on 12/22/2016
